Abivax (ABVX) Shares Outstanding (2021 - 2026)
Abivax (ABVX) posted quarterly Shares Outstanding (Entity) of $908.0 million for Q1 2026, up 24.58% year-over-year from $728.9 million in Q1 2025, and up 13.56% quarter-over-quarter from $799.6 million in Q4 2025.
Abivax (ABVX) Shares Outstanding (2021 - 2026) Analysis & Trends
Abivax's Shares Outstanding (Entity) history runs 6 years deep, the most recent figure standing at $908.0 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 24.58% year-over-year to $908.0 million; the TTM figure through Mar 2026 stood at $908.0 million (up 24.58% YoY), while the FY2025 annual figure was $799.6 million, up 10.28% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $908.0 million, up from $799.6 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $908.0 million in Q1 2026, with the low at $219.6 million in Q4 2022.
- The 5-year median for Shares Outstanding (Entity) is $727.1 million (2024), against an average of $692.6 million.
- The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) jumped 125.57% in 2023, then gained 0.73% in 2025.
- Abivax's Shares Outstanding (Entity) stood at $219.6 million in 2022, then soared by 125.57% to $495.3 million in 2023, then surged by 46.39% to $725.0 million in 2024, then rose by 10.28% to $799.6 million in 2025, then grew by 13.56% to $908.0 million in 2026.
- Business Quant data shows ABVX's Shares Outstanding (Entity) at $908.0 million in Q1 2026, $799.6 million in Q4 2025, and $838.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Abivax | 9.39 Bn | 9.39 Bn | - | 78.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78.96 Mn |
| Dec 31, 2025 | 69.53 Mn |
| Sep 30, 2025 | 72.94 Mn |
| Jun 30, 2025 | 63.44 Mn |
| Mar 31, 2025 | 63.38 Mn |
| Dec 31, 2024 | 63.05 Mn |
| Sep 30, 2024 | 63.23 Mn |
| Jun 30, 2024 | 62.92 Mn |
| Mar 31, 2024 | 62.92 Mn |
| Dec 31, 2023 | 43.07 Mn |
| Dec 31, 2022 | 19.09 Mn |
| Dec 31, 2021 | 15.46 Mn |